Skip to main content
. 2008 Apr 9;82(12):5869–5878. doi: 10.1128/JVI.02325-07

FIG. 3.

FIG. 3.

(A) Relative vitality values for recombinant PR with (PR1) and without (PR2) the E35EE insertion in the presence of various HIV PIs. (B) Relative vitality values for recombinant PR with (PR3) and without (PR4) the L33LL insertion in the presence of various HIV PIs. APV, amprenavir; ATV, atazanavir; BCV, brecanavir; DRV, darunavir; IDV, indinavir; NFV, nelfinavir; RTV, ritonavir; SQV, saquinavir; LPV, lopinavir.